Schwartz Jonathan David

See RemarksROCKET PHARMACEUTICALS, INC. (RCKT) · full profile →Form 4 · filed Feb 27, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$224K
Net Open-Market Flow
-$224K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 25, 2025Sell(S)7K$10.58$69K238K
Nov 21, 2024Sell(S)3K$13.05$40K164K
Aug 16, 2024Sell(S)3K$18.50$50K167K
May 17, 2024Sell(S)3K$23.35$64K170K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-006272) within minutes of acceptance. Every field above traces to the original document. Verify it directly: